Comparative Efficacy and Safety of Anticoagulation Therapy in the Management of Patients with Concurrent Pulmonary Embolism and Atrial Fibrillation: A Systematic Review and Meta-Analysis

Laraib Aurangzeb; Jawad Ahmad; Aimen Zeb; Qazi Muhammad Farooq Wahab; Muhammad Ayub; Aibad Ahmed Afridi; Hamad Qasim; Haroon Tahir; Ijaz Hussain; Shah Faisal Khan; Muhammad Amin Noor; Zahid

doi:10.70749/ijbr.v3i1.400

Authors

Laraib Aurangzeb Department of Pulmonology, Lady Reading Hospital, Peshawar, KP, Pakistan.
Jawad Ahmad Department of Internal Medicine, Khyber Teaching Hospital, Peshawar, KP, Pakistan.
Aimen Zeb Department of Pulmonology, Hayatabad Medical Complex, Peshawar, KP, Pakistan.
Qazi Muhammad Farooq Wahab Department of Internal Medicine, Hayatabad Medical Complex, Peshawar, KP, Pakistan.
Muhammad Ayub Department of Internal Medicine, DHQ Hospital, D.I. Khan, KP, Pakistan.
Aibad Ahmed Afridi Department of Internal Medicine, Hayatabad Medical Complex, Peshawar, KP, Pakistan.
Hamad Qasim Department of Internal Medicine, Khyber Teaching Hospital, Peshawar, KP, Pakistan.
Haroon Tahir Department of Internal Medicine, Lady Reading Hospital, Peshawar, KP, Pakistan.
Ijaz Hussain Department of General Medicine, Khyber Teaching Hospital, Peshawar, KP, Pakistan.
Shah Faisal Khan Department of Emergency Medicine, Lady Reading Hospital, Peshawar, KP, Pakistan.
Muhammad Amin Noor Department of Internal Medicine, Lady Reading Hospital, Peshawar, KP, Pakistan.
Zahid Department of Internal Medicine, Lady Reading Hospital, Peshawar, KP, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i1.400

Keywords:

Anticoagulation Therapy, Pulmonary Embolism, Atrial Fibrillation, Systematic Review, Meta-Analysis

Abstract

Background: Management of anticoagulation in patients with both pulmonary embolism (PE) and atrial fibrillation (AF) can be difficult. They also continue to be at a higher risk of embolic events including stroke and recurrent pulmonary embolism, but at the same time remain at a high risk of bleeding secondary to anticoagulation. Management of this dual diagnosis complicates the administration and dosing of anticoagulant medications with the dual aim of preventing thromboembolic events while at the same time not increasing the risk of haemorrhage. Objectives: The current meta-analysis and systematic review was designed to compare and assess the effectiveness and safety of DOACs compared to warfarin in individuals with both PE and AF with reference to TE, stroke risk, and bleeding. Methods: A PubMed, Cochrane Library, and Scopus search was performed for all articles comparing different anticoagulation regimes in the patients with both PE and AF. Inclusion criteria were RCTs and cohort studies of patients from 2010 to 2023. Meta-analysis used fixed/fixed or random/random models and efficacy and safety outcomes were estimated by RR and 95% CI. Results: DOACs were also reported to prevent recurrent PE (RR = 0.58, 95% CI [0.40–0.85]) and ischemic stroke (RR = 0.58, 95% CI [0.35–0.93]). Furthermore, DOACs was associated with less major bleedings (RR = 0.52; 95% CI [0.32–0.85] and intracranial hemorrhage (RR = 0.30; 95% CI [0.11–0.83]. Conclusion: Certain DOACs are superior to warfarin in the treatment of anticoagulation in patients with both PE and AF making the use of DOACs a possible pathway towards the management of both thromboembolic events and bleeding complications. These findings add credence to the general use of DOACs over the current traditional treatment in this high-risk group.

Downloads

Download data is not yet available.

References

Georgilis, S. (2023). Understanding venous thromboembolism and pulmonary embolism. Nursing made Incredibly Easy, 21(2), 31-36. https://doi.org/10.1097/01.nme.0000899388.18076.ce

Kaimakamis, E., & Chasapidou, G. (2022). Respiration: physiology, pathology, and treatment. In Wearable Sensing and Intelligent Data Analysis for Respiratory Management (pp. 3-28). Academic Press. https://doi.org/10.1016/B978-0-12-823447-1.00004-X

Motiwala, A., Tanwir, H., Duarte, A., Gilani, S., DeAnda, A., Zaidan, M. F., & Jneid, H. (2024). Multidisciplinary Approach to Pulmonary Embolism and the Role of the Pulmonary Embolism Response Team. Current Cardiology Reports, 26(8), 843-849. https://link.springer.com/article/10.1007/s11886-024-02084-9

Morrone, D., & Morrone, V. (2018). Acute pulmonary embolism: focus on the clinical picture. Korean circulation journal, 48(5), 365-381. https://doi.org/10.4070/kcj.2017.0314

Ware, W. A., Bonagura, J. D., & Scansen, B. A. (2021). Electrocardiography. In Cardiovascular Disease in Companion Animals (pp. 135-166). CRC Press. https://www.taylorfrancis.com/chapters/edit/10.1201/9780429186639-6/electrocardiography-wendy-ware-john-bonagura-brian-scansen

Ziff, O. J., Carter, P. R., McGowan, J., Uppal, H., Chandran, S., Russell, S., ... & Potluri, R. (2018). The interplay between atrial fibrillation and heart failure on long-term mortality and length of stay: Insights from the, United Kingdom ACALM registry. International journal of cardiology, 252, 117-121. https://doi.org/10.1016/j.ijcard.2017.06.033

Liang, F., & Wang, Y. (2021). Coronary heart disease and atrial fibrillation: a vicious cycle. American Journal of Physiology-Heart and Circulatory Physiology, 320(1), H1-H12. https://doi.org/10.1152/ajpheart.00702.2020

Soleimani, H., Tavakoli, K., Nasrollahizadeh, A., Azadnajafabad, S., Mashayekhi, M., Ebrahimi, P., ... & Hosseini, K. (2024). Estimating the burden of atrial fibrillation and atrial flutter with projection to 2050 in Iran. Scientific Reports, 14(1), 20264. https://www.nature.com/articles/s41598-024-71296-4

Duffett, L., Castellucci, L. A., & Forgie, M. A. (2020). Pulmonary embolism: update on management and controversies. Bmj, 370. https://doi.org/10.1136/bmj.m2177

Kornej, J., Börschel, C. S., Benjamin, E. J., & Schnabel, R. B. (2020). Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circulation research, 127(1), 4-20. https://doi.org/10.1161/CIRCRESAHA.120.316340

Klok, F. A., Ageno, W., Ay, C., Bäck, M., Barco, S., Bertoletti, L., ... & Pruszczyk, P. (2022). Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society. European heart journal, 43(3), 183-189. https://doi.org/10.1093/eurheartj/ehab816

Konstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G. J., Harjola, V. P., ... & Zamorano, J. L. (2020). 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). European heart journal, 41(4), 543-603. https://doi.org/10.1093/eurheartj/ehz405

Papakonstantinou, P. E., Kalogera, V., Charitos, D., Polyzos, D., Benia, D., Batsouli, A., ... & Lip, G. Y. (2024). When anticoagulation management in atrial fibrillation becomes difficult: Focus on chronic kidney disease, coagulation disorders, and cancer. Blood reviews, 101171. https://doi.org/10.1016/j.blre.2024.101171

Mangiardi, M., Pezzella, F. R., Cruciani, A., Alessiani, M., & Anticoli, S. (2024). Long-Term Safety and Efficacy of Lacosamide Combined with NOACs in Post-Stroke Epilepsy and Atrial Fibrillation: A Prospective Longitudinal Study. Journal of Personalized Medicine, 14(12), 1125. https://doi.org/10.3390/jpm14121125

Wongrakpanich, S., Wongrakpanich, A., Melhado, K., & Rangaswami, J. (2018). A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging and disease, 9(1), 143. https://doi.org/10.14336/AD.2017.0306

Sadeghi Hokmabadi, E., Daei Sorkhabi, A., Sarkesh, A., Sadigh-Eteghad, S., Mehdizadehfar, E., Sadeghpoor, Y., & Farhoudi, M. (2024). Efficacy and safety of direct oral anticoagulants versus warfarin in the treatment of cerebral venous sinus thrombosis. Acta Neurologica Belgica, 1-8. https://link.springer.com/article/10.1007/s13760-024-02586-x

Smith, T. J. (Ed.). (2023). Multi-Modality Interventional Imaging, An Issue of Interventional Cardiology Clinics, E-Book: Multi-Modality Interventional Imaging, An Issue of Interventional Cardiology Clinics, E-Book (Vol. 13, No. 1). Elsevier Health Sciences.

Abdullah, H. M., Ullah, W., Jafar, M. S., van Zyl, M., Saeed, R., Alam, M., ... & Fischman, D. L. (2021). Safety and efficacy of apixaban, rivaroxaban, and warfarin in end-stage renal disease with atrial fibrillation: a systematic review and meta-analysis. Cardiovascular Revascularization Medicine, 30, 26-32. https://doi.org/10.1016/j.carrev.2020.09.041

Carnicelli, A. P., Hong, H., Connolly, S. J., Eikelboom, J., Giugliano, R. P., Morrow, D. A., ... & COMBINE AF (A Collaboration Between Multiple Institutions to Better Investigate Non-Vitamin K Antagonist Oral Anticoagulant Use in Atrial Fibrillation) Investigators. (2022). Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation, 145(4), 242-255. https://doi.org/10.1161/CIRCULATIONAHA.121.056355

Hahn, K., & Lamparter, M. (2023). Prescription of DOACs in patients with atrial fibrillation at different stages of renal insufficiency. Advances in Therapy, 40(10), 4264-4281. https://link.springer.com/article/10.1007/s12325-023-02544-8

Mohan, A., Wanat, M. A., & Abughosh, S. M. (2019). Medication taking behaviors in patients taking warfarin versus direct oral anticoagulants: a systematic review. Expert review of cardiovascular Therapy, 17(6), 427-434. https://doi.org/10.1080/14779072.2019.1620600